Patrick Bilbo Organogenesis Holdings Inc. (ORGO) insider trading activity

Patrick Bilbo is Chief Operating Officer of Organogenesis Holdings Inc.. Currently has a direct ownership of 949,062 shares of ORGO, which is worth approximately $4.98 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 184,136 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 949K

17.3% 3M change

43.94% 12M change

Total Value Held $4.98 Million

Patrick Bilbo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	BUY Grant, award, or other acquisition	-	184,136 Added 16.25%	949,062 Class A Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$2,923 $3.7 p/Share	790 Reduced 0.1%	764,926 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$160,454 $3.7 p/Share	43,366 Reduced 5.36%	765,716 Class A Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$6,991 $2.8 p/Share	2,497 Reduced 0.31%	809,082 Class A Common Stock
Mar 28 2024	BUY Exercise of conversion of derivative security	$179,655 $1.18 p/Share	152,250 Added 15.8%	811,579 Class A Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	187,318 Added 22.12%	659,329 Class A Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,752 $3.48 p/Share	791 Reduced 0.17%	472,011 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$108,681 $3.68 p/Share	29,533 Reduced 5.88%	472,802 Class A Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$5,704 $2.13 p/Share	2,678 Reduced 0.53%	502,335 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	327,386 Added 39.33%	505,013 Class A Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$2,574 $2.75 p/Share	936 Reduced 0.52%	177,627 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$13,429 $2.92 p/Share	4,599 Reduced 2.51%	178,563 Class A Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$19,701 $7.89 p/Share	2,497 Reduced 1.34%	183,162 Class A Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$7,290 $7.78 p/Share	937 Reduced 0.5%	185,659 Class A Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	52,926 Added 22.1%	186,596 Class A Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	$43,848 $1.44 p/Share	30,450 Added 18.55%	133,670 Class A Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$49,516 $19.83 p/Share	2,497 Reduced 1.5%	164,120 Class A Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	10,782 Added 6.08%	166,617 Class A Common Stock

Patrick Bilbo

Chief Operating Officer

Canton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Value

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO

Account